16 employees
LungLife AI is a molecular diagnostics company that involves in the early detection and treatment of cancer.
2006
$26M
from 3 investors over 3 rounds
LungLife AI raised $26M on June 17, 2015
Investors: Syno Capital, Livzon and Greenwoods Asset Management